Prokidney (PROK) Treasury Shares (2021 - 2026)
Prokidney (PROK) reported Treasury Shares of $10089.0 for Q1 2026, down 98.71% year-over-year from $779856.0 in Q1 2025, and down 98.62% quarter-over-quarter from $733252.0 in Q4 2025.
Prokidney (PROK) Treasury Shares (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Treasury Shares data on file, last reported at $10089.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $10089.0, down 98.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $10089.0 (down 98.71% YoY), and the FY2025 annual result was $733252.0, down 58.24% from the prior year.
- Treasury Shares fell to $10089.0 in Q1 2026 per PROK's latest filing, from $733252.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $8.8 million in Q3 2022 and troughed at $10089.0 in Q1 2026.
- A 5-year average of $3.3 million and a median of $2.2 million in 2024 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2026: Treasury Shares jumped 315.18% in 2022, then plunged 98.71% in 2026.
- A 5-year view of Treasury Shares shows it stood at $8.4 million in 2022, then sank by 57.4% to $3.6 million in 2023, then plunged by 50.76% to $1.8 million in 2024, then tumbled by 58.24% to $733252.0 in 2025, then slumped by 98.62% to $10089.0 in 2026.
- Business Quant data shows PROK's Treasury Shares at $10089.0 in Q1 2026, $733252.0 in Q4 2025, and $740933.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | 10,089.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,089.00 |
| Mar 31, 2026 | 10,089.00 |
| Dec 31, 2025 | 733,252.00 |
| Dec 31, 2025 | 733,252.00 |
| Sep 30, 2025 | 740,933.00 |
| Sep 30, 2025 | 740,933.00 |
| Jun 30, 2025 | 742,684.00 |
| Jun 30, 2025 | 742,684.00 |
| Mar 31, 2025 | 779,856.00 |
| Mar 31, 2025 | 779,856.00 |
| Dec 31, 2024 | 1.76 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Dec 31, 2023 | 3.57 Mn |
| Dec 31, 2023 | 3.57 Mn |